TCBIO US EQUITY Financials Financials CIK: 1077428

TEXAS CAPITAL BANCSHARES INC/TX (TCBIO) Quant Factor Diagnostic & Fair Value Model

TEXAS CAPITAL BANCSHARES INC/TX (Ticker: TCBIO) is listed in the Financials sector (Financials). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$18.28

-1.19% Latest Close (2026-10-07)

Market Cap: -

P/E Ratio: 66.8

Momentum Strength 3M / 12M

-11.35%

1M: -8.00% 12M: 0.00%

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

25.5

SMA50: $19.88 SMA200: $20.17

Valuation Multiplier Trailing

66.8

Premium Multiple (> 30x P/E)

📊 Valuation & Multi-Factor Diagnostic

Premium Multiple (> 30x P/E)

TCBIO trades at 66.8x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1077428 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1077428

💡 Methodology & Frequently Asked Questions

Key reference details regarding TEXAS CAPITAL BANCSHARES INC/TX (TCBIO) valuation multiples, momentum factors, and point-in-time filing conventions.

How should TCBIO's current valuation multiple be interpreted? ↓

TCBIO trades at a trailing P/E of 66.8x within the Financials sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are TCBIO's key momentum and technical factor indicators? ↓

As of the latest close, TCBIO shows a 1-month return of -8.00%, 3-month return of -11.35%, and 12-month return of 0.00%, with a 14-day RSI of 25.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for TCBIO? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can TCBIO be incorporated into systematic factor models? ↓

TCBIO can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.